Sphingolipids, Natural-Bio Compounds and Immune Modulation Laboratory

Dr. Dorit Avni

Principal Researcher

Dr. Dorit Avni

Dr. Dorit Avni
Dr. Dorit Avni
Sphingolipids, Natural-Bio Compounds and Immune Modulation Laboratory
054-9815556
dorita@migal.org.il

We strive to understand the mechanisms of  inflammation and cancer  that underlie the involvement of sphingolipids  and to translate these laboratory discoveries into new therapies

 

Latest Publications

Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans. FASEB J

Huang WC, Liang J, Nagahashi M, Avni D, Yamada A, Maceyka M, Wolen AR, Kordula T, Milstien S, Takabe K, Oravecz T, Spiegel S.
Read Online
Dr. Dorit Avni
2016

Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors. Immunol Lett

Katz S, Ernst O, Avni D, Athamna M, Philosoph A, Arana L, Ouro A, Hoeferlin LA, Meijler MM, Chalfant CE, Gómez-Muñoz
Read Online
Dr. Dorit Avni
2016

The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer. Oncogenesis

NC Hait, D Avni, A Yamada, M Nagahashi, T Aoyagi, H Aoki, CI Dumur, Z Zelenko, EJ Gallagher, D Leroith, S Milstien, K Takabe and S Spiegel
Read Online
Dr. Dorit Avni
2015

Aberrant ORM (yeast)-like protein isoform 3 (ORMDL3) expression dysregulates ceramide homeostasis in cells and ceramide exacerbates allergic asthma in mice. J Allergy Clin Immunol

Oyeniran C, Sturgill JL, Hait NC, Huang WC, Avni D, Maceyka M, Newton J, Allegood JC, Montpetit A, Conrad DH, Milstien S, Spiegel S
Read Online
Dr. Dorit Avni
2015
More Publications